Skip to main content

bamlanivimab and etesevimab User Reviews & Ratings

bamlanivimab and etesevimab has an average rating of 1.0 out of 10 from a total of 1 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 100% reported a negative experience.

  • Covid
  • Taken for less than 1 month
  • July 29, 2022

For COVID-19 "I was on day 7 of Covid with mild symptoms and 2 hours after I received the monoclonals my heart rate spiked and I went to the hospital. I had a massive inflammatory response. I developed pericarditis and Costochondritis. It’s now 7 months later and I am still having significant heart problems and now have heart disease."

1 / 10
Was this helpful?YesNo
2 Report

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.

More about bamlanivimab and etesevimab (bamlanivimab / etesevimab)

Patient resources

Professional resources

Related treatment guides